Source document or public record

FDA 510(k) K210272 — LIAISON Anti-HAV

FDA 510(k) index record K210272. Device: LIAISON Anti-HAV. Applicant as listed: DiaSorin, Inc.. Decision date: 2021-02-09.

OtherU.S. Food and Drug Administration (FDA)2021-02-09

Source

"device_name": "LIAISON Anti-HAV"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K210272.

Device name: LIAISON Anti-HAV. Applicant as listed: DiaSorin, Inc..

Decision date: 2021-02-09. Decision wording: Substantially Equivalent.

Product code: LOL. Regulation: 21 CFR 866.3310. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.